European Commission approves Yuvanci for pulmonary arterial hypertension treatment

The European Commission has approved Yuvanci (macitentan 10 mg and tadalafil 40 mg), a single tablet combination therapy (STCT) for the...
22 hours ago
from: PharmaTimes

Combination Therapy, Johnson & Johnson, Macitentan, Medicine, Pulmonary hypertension, Tadalafil

More about this

- European Commission approves Yuvanci for pulmonary arterial hypertension treatment
The European Commission has approved Yuvanci (macitentan 10 mg and tadalafil 40 mg), a single tablet combination therapy (STCT) for the...
from: PharmaTimes

- J&J clinches EC approval for first single-pill PAH combo
The European Commission (EC) has approved Johnson and Johnson's Yuvanci (macitentan + tadalafil) for the treatment of pulmonary arterial...
from: Yahoo Finance